Quantinno Capital Management
ORKA icon

Quantinno Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Quantinno Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$660K Buy
7,926
+1,525
+24% +$144K ﹤0.01% 3026
2026
Q2 		$609K Buy
6,401
+1,225
+24% +$81.6K ﹤0.01% 2877
2026
Q1 		$254K Buy
+5,176
New +$180K ﹤0.01% 3114

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Remedium Capital Partners
Remedium Capital Partners Fort Lauderdale, Florida $274M AUM 288.41% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Quantinno Capital Management's ORKA Position: Q3 2026 in Review

Quantinno Capital Management increased its Oruka Therapeutics (ORKA) stake by 24% in Q3 2026, buying an estimated $144K and bringing the position to 7,926 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Quantinno Capital Management first reported a position in ORKA in Q1 2026 and has held it in 3 quarters since. 175 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Quantinno Capital Management held 7,926 shares of Oruka Therapeutics worth $660K as of Q3 2026.
  • Quantinno Capital Management bought 1,525 Oruka Therapeutics shares in Q3 2026, an estimated $144K.
  • Oruka Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3026 holding.
  • Quantinno Capital Management first reported a position in Oruka Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 175 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.